-
Mashup Score: 1Home - 2 day(s) ago
Activity Overview
Source: events.medscapelive.orgCategories: General Medicine NewsTweet
-
Mashup Score: 1Advancements in Breast Cancer Treatment | PBCC 2025 - 3 day(s) ago
Register now for the 5th Annual Perspectives in Breast Cancer Care, September 12-13, 2025 and explore groundbreaking advancements in breast cancer treatment. Stay informed with the latest innovations shaping the future of breast cancer care and research.
Categories: General Medicine NewsTweet-
📢 SAVE THE DATE! Join us at Perspectives in Breast Cancer Care 🩺 Sept 12–13, 2025, Park Hyatt DC. 🌟 Early bird rates start at $440—deadline June 1, 2025. Register now! 👉 https://t.co/nxGhOE0Mxe #BreastCancerCare #PBCClive25 https://t.co/4xKjVdLwZf
-
-
Mashup Score: 1Home - 5 day(s) ago
Friday, September 5, 2025 11:47 am – 12:47 pm CT George R. Brown Convention Center | Houston, TX Room: Grand Ballroom A (Theater Room 1), Level 3 CME/CNE/CPE Hybrid This 60-minute symposium will feature a panel of experts in multiple myeloma who will review the intricacies of induction therapy and interventions in high-risk smoldering myeloma. They will provide expert guidance and real-world perspectives on risk assessment and individualized management in first-line therapy. Attendees will be able to
Source: events.medscapelive.orgCategories: General Medicine NewsTweet-
📊 New insights for newly diagnosed multiple myeloma are here! Learn how to apply emerging clinical evidence and confidently tailor treatment strategies for your patients. 🔗 https://t.co/fkk5YHROAY #SOHO2025 #MyelomaUpdate https://t.co/fzZ6kk2BmR
-
-
Mashup Score: 0Home - 7 day(s) ago
Wednesday, September 3, 2025 11:56 am – 12:56 pm CT George R. Brown Convention Center | Houston, Texas Room: Grand Ballroom A (Theater Room 1), Level 3 CME/CNE/CPE Hybrid This 60-minute live symposium will feature 3 experts in acute leukemias discussing lessons learned from the use of asparaginase-based multiagent regimens for ALL/LBL in pediatric patients and best practices for optimizing management of asparaginase therapies in adult patients with ALL/LBL. Drs Stock, Aldoss, and Curran will review
Source: events.medscapelive.orgCategories: General Medicine NewsTweet-
🧪 Stay sharp on therapeutic monitoring in acute lymphoblastic leukemia/lymphoma! Boost your confidence in managing asparaginase regimens, especially in younger adults. 🔗 https://t.co/lqolRpKHte #SOHO2025 #LeukemiaCare https://t.co/PBLqIkRx35
-
-
Mashup Score: 1Advancements in Breast Cancer Treatment | PBCC 2025 - 7 day(s) ago
Register now for the 5th Annual Perspectives in Breast Cancer Care, September 12-13, 2025 and explore groundbreaking advancements in breast cancer treatment. Stay informed with the latest innovations shaping the future of breast cancer care and research.
Categories: General Medicine NewsTweet-
📢 SAVE THE DATE! Join us at Perspectives in Breast Cancer Care 🩺 Sept 12–13, 2025, Park Hyatt DC. 🌟 Early bird rates start at $440—deadline June 1, 2025. Register now! 👉 https://t.co/nxGhOE0Mxe #BreastCancerCare #PBCClive25 https://t.co/4xKjVdLwZf
-
-
Mashup Score: 1Advancements in Breast Cancer Treatment | PBCC 2025 - 10 day(s) ago
Register now for the 5th Annual Perspectives in Breast Cancer Care, September 12-13, 2025 and explore groundbreaking advancements in breast cancer treatment. Stay informed with the latest innovations shaping the future of breast cancer care and research.
Categories: General Medicine NewsTweet-
📢 SAVE THE DATE! Join us at Perspectives in Breast Cancer Care 🩺 Sept 12–13, 2025, Park Hyatt DC. 🌟 Early bird rates start at $440—deadline June 1, 2025. Register now! 👉 https://t.co/nxGhOE0Mxe #BreastCancerCare #PBCClive25 https://t.co/4xKjVdLwZf
-
-
Mashup Score: 3Home - 11 day(s) ago
Thursday, 12 June 2025 08:00 – 09:30 CEST Allianz MiCo – Milano Convention Centre | 20149 Milan, Italy Room: Brown Hall 3 CPD Hybrid Multiple myeloma (MM) remains a challenging hematologic malignancy, with most patients experiencing relapse despite initial treatment success. The management of relapsed/refractory MM (R/R MM) has evolved significantly with the advent of novel therapies, including immunomodulatory drugs, proteasome inhibitors, monoclonal antibodies, and chimeric antigen receptor (CAR)
Source: events.medscapelive.orgCategories: General Medicine NewsTweet-
🧬 Understand how prognosis evolves through relapse cycles in MM. Gain confidence in SDM, 💊personalize treatment, and 🤝 improve communication in R/R MM care. 🔗 https://t.co/C7tcZh6Xc4 Moderated by: @jmikhaelmd https://t.co/Y6TD5omzkZ
-
-
Mashup Score: 1Advancements in Breast Cancer Treatment | PBCC 2025 - 14 day(s) ago
Register now for the 5th Annual Perspectives in Breast Cancer Care, September 12-13, 2025 and explore groundbreaking advancements in breast cancer treatment. Stay informed with the latest innovations shaping the future of breast cancer care and research.
Categories: General Medicine NewsTweet-
📢 SAVE THE DATE! Join us at Perspectives in Breast Cancer Care 🩺 Sept 12–13, 2025, Park Hyatt DC. 🌟 Early bird rates start at $440—deadline June 1, 2025. Register now! 👉 https://t.co/nxGhOE0Mxe #BreastCancerCare #PBCClive25 https://t.co/4xKjVdLwZf
-
-
Mashup Score: 5Mid-Year Updates on Radiopharmaceuticals in Prostate Cancer - 14 day(s) ago
Join distinguished experts Drs Bertrand Tombal, Pedro Barata, and Alicia Morgans as they examine cutting-edge developments in radiopharmaceutical therapies f…
Source: www.youtube.comCategories: General Medicine NewsTweet-
Sharpen your approach to mCRPC with the latest, most revolutionary trial data, and expert guidance via @BertrandTOMBAL @PBarataMD @CaPsurvivorship on applying it to your practice. ICYMI at major meetings this year 💥 https://t.co/z2rnYIXwWq https://t.co/AZxtshGJ9V
-
-
Mashup Score: 1Home - 15 day(s) ago
Activity Overview
Source: events.medscapelive.orgCategories: General Medicine NewsTweet-
🚨 Are you confident managing BRAF-mutated mCRC? 🧪 Master biomarker testing 🧬 Apply molecular data to guide therapy 🤝 Optimize MDT coordination 💡 Learn what’s working now → https://t.co/E35K3hnAcW #ESMOGI25 https://t.co/ffJTyC7Xo7
-
🔬 New trial data on immunotherapy for resectable gastric/GEJ cancers is here!👩⚕️ Gain confidence in identifying patients who may benefit from perioperative IO. Join here now: https://t.co/xRvW798hFW 🗣️ @YJanjigianMD #Oncology #GastricCance https://t.co/9g81eHZDfA